These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 21128658)
1. Enhancement of drug absorption through the blood-brain barrier and inhibition of intercellular tight junction resealing by E-cadherin peptides. Kiptoo P; Sinaga E; Calcagno AM; Zhao H; Kobayashi N; Tambunan US; Siahaan TJ Mol Pharm; 2011 Feb; 8(1):239-49. PubMed ID: 21128658 [TBL] [Abstract][Full Text] [Related]
2. Improving Eflornithine Oral Bioavailability and Brain Uptake by Modulating Intercellular Junctions With an E-cadherin Peptide. Yang S; Chen Y; Feng M; Rodriguez L; Wu JQ; Wang MZ J Pharm Sci; 2019 Dec; 108(12):3870-3878. PubMed ID: 31545969 [TBL] [Abstract][Full Text] [Related]
3. Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood-brain barrier permeability. Laksitorini MD; Kiptoo PK; On NH; Thliveris JA; Miller DW; Siahaan TJ J Pharm Sci; 2015 Mar; 104(3):1065-75. PubMed ID: 25640479 [TBL] [Abstract][Full Text] [Related]
4. Increasing paracellular porosity by E-cadherin peptides: discovery of bulge and groove regions in the EC1-domain of E-cadherin. Sinaga E; Jois SD; Avery M; Makagiansar IT; Tambunan US; Audus KL; Siahaan TJ Pharm Res; 2002 Aug; 19(8):1170-9. PubMed ID: 12240943 [TBL] [Abstract][Full Text] [Related]
5. Reversible Opening of Intercellular Junctions of Intestinal Epithelial and Brain Endothelial Cells With Tight Junction Modulator Peptides. Bocsik A; Walter FR; Gyebrovszki A; Fülöp L; Blasig I; Dabrowski S; Ötvös F; Tóth A; Rákhely G; Veszelka S; Vastag M; Szabó-Révész P; Deli MA J Pharm Sci; 2016 Feb; 105(2):754-765. PubMed ID: 26869428 [TBL] [Abstract][Full Text] [Related]
6. Improving the selectivity of HAV-peptides in modulating E-cadherin-E-cadherin interactions in the intercellular junction of MDCK cell monolayers. Makagiansar IT; Avery M; Hu Y; Audus KL; Siahaan TJ Pharm Res; 2001 Apr; 18(4):446-53. PubMed ID: 11451030 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain. Alaofi A; On N; Kiptoo P; Williams TD; Miller DW; Siahaan TJ J Pharm Sci; 2016 Feb; 105(2):797-807. PubMed ID: 26869430 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of e-cadherin-mediated homotypic adhesion of Caco-2 cells: a novel evaluation assay for peptide activities in modulating cell-cell adhesion. Kobayashi N; Ikesue A; Majumdar S; Siahaan TJ J Pharmacol Exp Ther; 2006 Apr; 317(1):309-16. PubMed ID: 16371447 [TBL] [Abstract][Full Text] [Related]
9. Maintenance of the epithelial barrier in a bronchial epithelial cell line is dependent on functional E-cadherin local to the tight junctions. West MR; Ferguson DJ; Hart VJ; Sanjar S; Man Y Cell Commun Adhes; 2002; 9(1):29-44. PubMed ID: 12200963 [TBL] [Abstract][Full Text] [Related]
10. Characterization of multiple stable conformers of the EC5 domain of E-cadherin and the interaction of EC5 with E-cadherin peptides. Zheng K; Laurence JS; Kuczera K; Verkhivker G; Middaugh CR; Siahaan TJ Chem Biol Drug Des; 2009 Jun; 73(6):584-98. PubMed ID: 19635050 [TBL] [Abstract][Full Text] [Related]
11. Targeting the tight junction protein, zonula occludens-1, with the connexin43 mimetic peptide, αCT1, reduces VEGF-dependent RPE pathophysiology. Obert E; Strauss R; Brandon C; Grek C; Ghatnekar G; Gourdie R; Rohrer B J Mol Med (Berl); 2017 May; 95(5):535-552. PubMed ID: 28132078 [TBL] [Abstract][Full Text] [Related]
12. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Deli MA Biochim Biophys Acta; 2009 Apr; 1788(4):892-910. PubMed ID: 18983815 [TBL] [Abstract][Full Text] [Related]
13. (1)H, (13)C and (15)N backbone assignment of the EC-1 domain of human E-cadherin. Prasasty VD; Krause ME; Tambunan US; Anbanandam A; Laurence JS; Siahaan TJ Biomol NMR Assign; 2015 Apr; 9(1):31-5. PubMed ID: 24510398 [TBL] [Abstract][Full Text] [Related]
14. Adropin reduces paracellular permeability of rat brain endothelial cells exposed to ischemia-like conditions. Yang C; DeMars KM; Hawkins KE; Candelario-Jalil E Peptides; 2016 Jul; 81():29-37. PubMed ID: 27020249 [TBL] [Abstract][Full Text] [Related]
16. Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarized intestinal epithelia. Walsh SV; Hopkins AM; Chen J; Narumiya S; Parkos CA; Nusrat A Gastroenterology; 2001 Sep; 121(3):566-79. PubMed ID: 11522741 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of adherens junction components in blood-brain barrier microvessels of the rat. Schulze C; Firth JA J Cell Sci; 1993 Mar; 104 ( Pt 3)():773-82. PubMed ID: 8314872 [TBL] [Abstract][Full Text] [Related]
18. Structure and function of the intercellular junctions: barrier of paracellular drug delivery. Zheng K; Trivedi M; Siahaan TJ Curr Pharm Des; 2006; 12(22):2813-24. PubMed ID: 16918412 [TBL] [Abstract][Full Text] [Related]
19. Acetaldehyde dissociates the PTP1B-E-cadherin-beta-catenin complex in Caco-2 cell monolayers by a phosphorylation-dependent mechanism. Sheth P; Seth A; Atkinson KJ; Gheyi T; Kale G; Giorgianni F; Desiderio DM; Li C; Naren A; Rao R Biochem J; 2007 Mar; 402(2):291-300. PubMed ID: 17087658 [TBL] [Abstract][Full Text] [Related]
20. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Greene C; Campbell M Tissue Barriers; 2016; 4(1):e1138017. PubMed ID: 27141420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]